Gary Smith

Ciena Corp (NYSE: CIEN) shares are trading lower Thursday after the company reported worse-than-expected financial results. Ciena said fiscal second-quarter revenue increased 13.8% year-over-year to $949.2 million, which came in below the estimate of $950.83 million, according to data from ...

FDA Expands Psychiatric Indications For Nasal Spray Ketamine Last week, the FDA approved suicidal tendencies as additional qualifying symptoms for the application of Spravato, a ketamine nasal spray used in psychiatric treatment. Spravato is the brand name for esketamine, a chemical sibling of...

Shares of Ciena Corporation (NYSE: CIEN) rebounded slightly higher on Friday following Thursday's sharp selloff. Ciena reported better-than-expected fourth-quarter results and a weak revenue forecast Thursday morning. Following the quarterly results and weak guidance, management hosted a...